Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
18 angezeigte Treffer · Seite 1, keine Gesamtzahl für „attributed“
Suchtreffer
Begriffe & Kennungen
Casgevy · 4.8 · Serious adverse reactions attributed to Casgevy occurred in 2 (3.7%) patients with TDT: 1 (1.9%) patient with
Eintrag öffnenCasgevy · 4.8 · Table 1: Adverse reactions attributed to mobilisation/apheresis in patients with TDT receiving G-CSF and pleri
Eintrag öffnenCasgevy · 4.8 · Table 2: Adverse reactions attributed to mobilisation/apheresis in patients with SCD receiving plerixafor (N=5
Eintrag öffnenCasgevy · 4.8 · Table 3: Adverse reactions attributed to myeloablative conditioning with busulfan in patients with TDT and SCD
Eintrag öffnenCasgevy · 4.8 · Table 4: Adverse reactions attributed to Casgevy in patients with TDT and SCD (N=97) * System organ class (SOC
Eintrag öffnenCasgevy · 4.8 · Tables 1, 2, 3, and 4 are lists of adverse reactions attributed to mobilisation/apheresis with G-CSF and pleri
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.8 · 7 ADRs attributed to moxifloxacin are marked with §.
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.8 · 9 Δ: ADRs that are attributed to linezolid. §: ADRs that are attributed to Moxifloxacin
Eintrag öffnenFuzeon · 4.8 · 5 Table 2: Adverse reactions attributed to treatment with Fuzeon in studies TORO 1 and TORO 2 combined
Eintrag öffnenFuzeon · 4.8 · In addition there have been a small number of hypersensitivity reactions attributed to enfuvirtide and in some
Eintrag öffnenIncresync · 4.8 · Acute pancreatitis is a serious adverse reaction and is attributed to the alogliptin component of Incresync (s
Eintrag öffnenMircera · 4.8 · 8 Table 3: Adverse reactions attributed to the treatment with methoxy polyethylene glycol- epoetin beta in CKD
Eintrag öffnenNeoRecormon · 4.8 · 11 Table 1: Adverse reactions attributed to the treatment with NeoRecormon in controlled clinical trials in CK
Eintrag öffnenNeoRecormon · 4.8 · Table 2: Adverse reactions attributed to the treatment with NeoRecormon in controlled clinical trials in cance
Eintrag öffnenNeoRecormon · 4.8 · Table 3: Adverse reactions attributed to the treatment with NeoRecormon in controlled clinical trials in patie
Eintrag öffnenSuboxone · 4.8 · In cases of intravenous drug misuse, some adverse reactions are attributed to the act of misuse rather than th
Eintrag öffnenVipdomet · 4.8 · Acute pancreatitis is a serious adverse reaction and is attributed to the alogliptin component of Vipdomet (se
Eintrag öffnenZubsolv · 4.8 · In cases of intravenous drug misuse, some adverse reactions are attributed to the act of misuse rather than th
Eintrag öffnen